A model using a simpler and clearer patient leaflet has been elaborated. The efficacy and risks of each product are to be explained and compared to those of their competitor’s. The results on research carried out on drugs are of paramount importance to consumers interested in acheter un médicament de prescription 20mg . On how many people has the treatment been tested? Has it been compared to other drugs and a placebo in terms of efficacy and side effects? This information is collected during clinical trials on medicines, so why is it not shared with the general public so that they may make more informed choices about the medications they are prescribed? It would take one person a considerable amount of time to sift through all the research papers collated by the American Food and Drugs Administration (FDA), the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), however the information is available to anyone who is interested.
The sheer vastness of information and bodies holding details on drugs makes it difficult for both patients and doctors alike to keep on top of which drugs are best. For this reason two researchers at the American University of Dartmouth propose that a Drugs Facts Box is included with every medicine. The facts box would concisely present research findings on each medicine relating to efficacy and side effects, and would serve to complement the current patient leaflets supplied by the manufacturers. Manufacturers of leading drugs brands, like Pfizer who produce Viagra, are strongly against the motion to supply this information as it would be damaging to their product brand and sales. When millions or even billions of dollars are at stake there is little wonder the proposal is unpopular with pharmaceutical giants. For this reason it is unlikely that the proposal be implemented any time soon.
Medical experts believe that presenting information about medicines more clearly is a step in the right direction, and moves have already made in recent years to dumb down the language used in patient leaflets, so that instructions, precautions and drug interactions are clearly displayed to patients in plain English. These steps were taken in a bid to improve drug safety and avoid patients taking medicines incorrectly despite being provided with the information during a patient consultation with their doctor. Experts worry this information may overshadow patient-specific treatment decisions made by a doctor, and lead to patients self-treating when they are unable to obtain medicines through the official channels.
The facts box should be informative, but putting products head to head is unnecessary and likely to cause confusion. Decisions about treatments should follow a thorough discussion between a patient and a medical profession where the pros and cons of medications is carefully considered on a case by case basis.